About   Help   FAQ
Mammalian Phenotype Ontology Annotations
Query Results - Summary
Symbol
Name
ID
Tgfbr1
transforming growth factor, beta receptor I
MGI:98728
79 phenotypes from 11 alleles in 18 genetic backgrounds
Export: Excel File
Allelic Composition
Genetic Background
Annotated Term Reference
Cd207tm2.1(cre)Bjec/Cd207+
Tgfbr1tm1.1Karl/Tgfbr1tm1.1Karl
involves: 129S4/SvJaeSor * C57BL/6
abnormal type IV hypersensitivity reaction J:179630
decreased dendritic cell number J:179630
Gt(ROSA)26Sortm1(Tgfbr1*)Crm/Gt(ROSA)26Sor+
Tg(Col1a2-cre/ERT,-ALPP)7Cpd/0
involves: 129S7/SvEvBrd * C57BL/6 * DBA/2
abnormal artery morphology J:134135
abnormal blood vessel morphology J:134135
abnormal blood vessel physiology J:134135
abnormal dermal layer morphology J:134135
abnormal kidney arterial blood vessel morphology J:134135
abnormal lung vasculature morphology J:134135
abnormal skin condition J:134135
decreased body weight J:134135
decreased subcutaneous adipose tissue amount J:134135
renal interstitial fibrosis J:134135
sparse hair J:134135
thick dermal layer J:134135
thick skin J:134135
thin epidermis J:134135
vascular smooth muscle hypertrophy J:134135
Hprt1tm1(CAG-Tgfbr1*)Lba/Hprt1tm1(CAG-Tgfbr1*)Lba
Tg(Cd4-cre)1Cwi/0
involves: 129 * C57BL/6 * DBA/2
abnormal T cell activation J:148747
Hprt1tm1(CAG-Tgfbr1*)Lba/Y
Tg(Cd4-cre)1Cwi/0
involves: 129 * C57BL/6 * DBA/2
abnormal T cell activation J:148747
Tg(Col2a1-cre/ERT2)1Dic/0
Tgfbr1tm1.1Karl/Tgfbr1tm1.1Karl
involves: 129 * C57BL/6
abnormal articular cartilage morphology J:271724
abnormal synovial joint morphology J:271724
increased chondrocyte apoptosis J:271724
osteoarthritis J:271724
osteophytes J:271724
Tgfbr1R244Q/Tgfbr1+
either: (involves: C57BL/6) or (involves: BALB/c * C57BL/6)
abnormal cartilage development J:175236
enhanced wound healing J:175236
Tgfbr1R244Q/Tgfbr1R244Q
either: (involves: C57BL/6) or (involves: BALB/c * C57BL/6)
abnormal cartilage development J:175236
enhanced wound healing J:175236
Tgfbr1tm1.1Hcd/Tgfbr1+
129S6(Cg)-Tgfbr1tm1.1Hcd
abnormal aorta bulb morphology J:204960
abnormal aorta elastic fiber morphology J:204960
abnormal aortic arch morphology J:204960
abnormal coronary artery morphology J:204960
aortic dissection J:204960
ascending aorta aneurysm J:204960
dilated aorta bulb J:204960
hemopericardium J:204960
hemothorax J:204960
increased aorta wall thickness J:204960
kyphosis J:204960
premature coronal suture closure J:204960
premature cranial suture closure J:204960
premature death J:204960
premature lambdoid suture closure J:204960
Tgfbr1tm1.1Karl/Tgfbr1tm1.1Karl
A1cfTg(Myh6-cre/Esr1*)1Jmk/A1cf+
involves: 129S/Sv * C57BL/6 * FVB/N
normal cardiovascular system phenotype J:164749
decreased cardiac muscle contractility J:164749
dilated cardiomyopathy J:164749
premature death J:164749
Tgfbr1tm1.1Karl/Tgfbr1tm1.1Karl
Tg(Acvrl1-cre)L1Spo/0
involves: 129 * FVB
normal cardiovascular system phenotype J:130020
no abnormal phenotype detected J:130020
Tgfbr1tm1.1Karl/Tgfbr1tm1.1Karl
Tg(Mx1-cre)1Cgn/0
involves: 129 * C57BL/6 * CBA
normal hematopoietic system phenotype J:86262
increased hematopoietic stem cell proliferation J:86262
Tgfbr1tm1.1Karl/Tgfbr1tm1.1Karl
Tg(Nes-cre)1Atp/0
involves: 129 * FVB/N
abnormal medial nasal prominence morphology J:138715
abnormal palatal shelf morphology J:138715
bilateral cleft upper lip J:138715
cleft upper lip J:138715
lethality throughout fetal growth and development, complete penetrance J:138715
maxillary prominence hypoplasia J:138715
palatal shelf hypoplasia J:138715
unilateral cleft upper lip J:138715
Tgfbr1tm1.1Karl/Tgfbr1tm1.1Karl
Tg(Tie1-cre)9Ref/0
either: (involves: 129S1/Sv * 129X1/SvJ) or (involves: 129S1/Sv * 129S6/SvEvTac * 129X1/SvJ)
abnormal vitelline vasculature morphology J:98373
prenatal lethality, complete penetrance J:98373
Tgfbr1tm1.1Vlcg/Tgfbr1tm1.1Vlcg
involves: 129S6/SvEvTac * C57BL/6NTac
no abnormal phenotype detected J:200671
Tgfbr1tm1Bopa/Tgfbr1tm1Bopa
B6.129S1-Tgfbr1tm1Bopa
embryonic lethality, complete penetrance J:143706
Tgfbr1tm1Dgen/Tgfbr1tm1Dgen
involves: 129P2/OlaHsd * C57BL/6
preweaning lethality, complete penetrance J:101679
Tgfbr1tm1Karl/Tgfbr1tm1.1Karl
Tg(GATA5-cre)1Krc/0
involves: 129
abnormal bronchiole epithelium morphology J:157922
abnormal lung development J:157922
abnormal pulmonary alveolus morphology J:157922
abnormal skin development J:157922
decreased club cell number J:157922
dilated respiratory conducting tube J:157922
neonatal lethality, complete penetrance J:157922
small lung J:157922
Tgfbr1tm1Karl/Tgfbr1tm1Karl
Not Specified
abnormal angiogenesis J:68770
abnormal neural tube morphology J:68770
abnormal placenta labyrinth morphology J:68770
abnormal visceral yolk sac morphology J:68770
absent vitelline blood vessels J:68770
decreased embryo size J:68770
embryonic growth retardation J:68770
embryonic lethality during organogenesis, complete penetrance J:68770
kinked neural tube J:68770
pericardial effusion J:68770
Tgfbr1tm1Mulm/Tgfbr1tm1Mulm
involves: 129P2/OlaHsd
absent vitelline blood vessels J:128498
embryonic lethality during organogenesis, complete penetrance J:128498
Tgfbr1tm1Spo/Tgfbr1tm1Spo
either: (involves: 129S4/SvJae) or (involves: 129 * C57BL/6)
abnormal vascular smooth muscle morphology J:104918
abnormal vitelline vascular remodeling J:104918
embryonic growth retardation J:104918
embryonic lethality during organogenesis, complete penetrance J:104918
excessive folding of visceral yolk sac J:104918

Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/16/2024
MGI 6.23
The Jackson Laboratory